Drug delivery systems (DDS) are developed for drugs with nonideal properties, such as poor solubility, tissue damage, and loss of drug activity after administration. The formulation of pharmacologically active drug molecules in DDS can improve or abolish toxic side effects and suboptimal therapeutic effects. This article focuses on DDSs for the delivery of peptides, DNA, plasmids, oligodeoxynucleotides, siRNA, and lipophilic nucleoside derivatives.